Calendar

Events in April 2024

Monday Tuesday Wednesday Thursday Friday
April 1, 2024 April 2, 2024 April 3, 2024 April 4, 2024 April 5, 2024
April 8, 2024 April 9, 2024 April 10, 2024 April 11, 2024 April 12, 2024
April 15, 2024 April 16, 2024 April 17, 2024 April 18, 2024 April 19, 2024
April 22, 2024 April 23, 2024 April 24, 2024 April 25, 2024 April 26, 2024
April 29, 2024 April 30, 2024 May 1, 2024 May 2, 2024 May 3, 2024

Get Our Monthly Newsletter

Stay informed on the latest offerings and treatments available at Norton Healthcare by subscribing to our monthly enewsletter.

Subscribe

Make a Referral

Partnering with you in caring for your patients.

Refer a Patient
Are You a Patient?
Provider Spotlight

Christopher P. Rhyne, M.D.

Christopher P. Rhyne, M.D., has joined Norton Neuroscience Institute as a headache medicine specialist.

Read More

Phase 1 cystic fibrosis trial studying novel enzyme replacement therapy in adults

Patients 18 years of age and older with cystic fibrosis now have an option of participating in a Phase 1 trial of a novel, broad-spectrum, orally delivered enzyme replacement therapy for cystic fibrosis (CF). The [...]

Read Full Story

Sciatic neuropathy case study: 4-centimeter tumor discovered on sciatic nerve

The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. [...]

Read Full Story

March 2024 Norton Children’s Medical Group New Providers

Pamela C Biddle, M.D. Pediatrics Jessica N.B. Easterling, M.D. Pediatrics Kelly E Kries, MD ­ Pediatrics Casey L Miles, MD Pediatrics Danielle R. Lunsford, APRN Developmental-Behavioral Pediatrics Mary C. Oechslin, APRN Pediatrics Chelsea R. Sabelhaus, […]

Read Full Story

March 2024 Norton Medical Group new providers

Paul A. Kniery, M.D. Internal Medicine Stephen Love, M.D. Behavioral Medicine Sarah A. Mayfield, M.D. Internal Medicine Emmanuel A. Nidhiry, M.D. Medical Oncology and Hematology Anupama Raghuram, M.D. Infectious Diseases Elizabeth Fahey, PA-C Hand Surgery […]

Read Full Story

Updated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s

In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]

Read Full Story

Search our entire site.